Skip to main content

The combined effect of food additive titanium dioxide and lipopolysaccharide on mouse intestinal barrier function after chronic exposure of titanium dioxide-contained feedstuffs



Up to 44% of particulates of food-grade titanium dioxide (TiO2) are in nanoscale, while the effect and combined effect of which with other substances on intestinal barrier haven’t been fully understood yet. This study is aimed to study the effect of two kinds of TiO2 nanoparticles (TiO2 NPs and TiO2 MPs) on intestinal barrier functions, to reveal the combined effect of TiO2 NPs and Lipopolysaccharide (LPS) on intestinal barrier.


Male ICR mice were randomly divided into 18 groups (3 feed types * 3 exposure length * 2 LPS dosage) and were fed with normal or TiO2-mixed feed (containing 1% (mass fraction, w/w) TiO2 NPs or TiO2 MPs) for 1, 3, 6 months, followed by a single oral administration of 0 or 10 mg/(kg body weight) LPS. Four hours later, the transportation of TiO2, the intestinal barrier functions and the inflammatory response were evaluated.


Both TiO2 notably increased the intestinal villi height / crypt depth ratios after 1 and 3 months of exposure, and increased the expression of ileal tight junction proteins (ZO-1 and occludin) after 1 month of exposure. After 6 months of exposure, TiO2 NPs led to reduced feed consumption, TiO2 MPs caused spare microvilli in small intestine and elevated Ti content in the blood cells. The intestinal permeability didn’t change in both TiO2 exposed groups. After LPS administration, we observed altered intestinal villi height / crypt depth ratios, lowered intestinal permeability (DAO) and upregulated expression of ileal ZO-1 in both (TiO2 +LPS) exposed groups. There are no significant changes of ileal or serum cytokines except for a higher serum TNF-α level in LPS treated group. The antagonistic effect was found between TiO2 NPs and LPS, but there are complicated interactions between TiO2 MPs and LPS.


Long-term intake of food additive TiO2 could alter the intestinal epithelial structure without influencing intestinal barrier function. Co-exposure of TiO2 and LPS would enhance intestinal barrier function without causing notable inflammatory responses, and there is antagonistic effect between TiO2 NPs and LPS. All the minor effects observed might associate with the gentle exposure method where TiO2 being ingested with feed.


Titanium dioxide (TiO2) is an important inorganic white pigment, and is widely used as an additive in food sector, including meat, minced fish, candy, bakery, cheese, sugar, spices, and food supplements. Considering the differences in eating habits, the daily TiO2 intake fluctuated between 0 and 112 mg/person [1, 2]. As TiO2 has the highest concentrations in candy, chewing gum and chocolate, children became the high exposure crowd. In 2012, it was estimated that the intake of TiO2 for every UK child under the age of 10 is 2 to 3 mg/kg per day, and every adult ingests 1 mg/kg TiO2 a day [3]. With the development of nanotechnology, a large number of nanoscale TiO2 have been produced and used. Studies have shown that 17–36% [4, 5] of food grade TiO2 particles are in nano-size, the variation is probably caused by different manufacturing methods. It was also reported that TiO2 particles extracted from commercial foods have 10–44% particles in nano-size [1, 6]. These TiO2 NPs can be ingested with food, which will lead to direct exposure of the digestive tract to TiO2 nanoparticles (NPs).

The intestinal tract is the main site for water and nutrients absorption, and is also an important barrier against invasions of foreign materials. These functions mainly depend on the integrity of the intestinal epithelial cell barrier, which is composed of intestinal epithelial cells and intercellular connections. In the intact intestinal barrier epithelium, the intercellular space is sealed by the apical junction complex, including tight junction which closes gaps between cells [7,8,9,10]. The body can directly regulate the permeability of the intestinal barrier by regulating the function of tight junction which consists of a variety of proteins, like occludin, claudin, zonula occludens (ZO), and myosin light chain kinase [11,12,13,14]. Mild mucosal epithelial damage may promote foreign materials to cross intestinal mucosal epithelium, which in turn may induce T helper cell 1 (Th1) or Th2 mediated inflammatory response characterized by increased level of tumor necrosis factor (TNF), interferon-γ (IFN- γ) and interleukin-13 (IL-13), these cytokines can impact on tight junction proteins and increase tight junction permeability which will allow more bacterial products or food antigens to cross the intestinal barrier [9, 13, 15]. This feedback will amplify inflammation and eventually leads to disease. Conversely, if the foreign materials triggered the differentiation of regulatory T (Treg) cells, intestinal mucosal hemostasis will be promoted as Th-1 cell differentiation would be suppressed, in addition, IL-10 and transforming growth factor β (TGF-β) secreted by Treg cells and retinoic acid secreted by epithelial cells would enhance tight junction integrity and maintain intestinal mucosal hemostasis [15].

Acute and subchronic oral toxicity studies have shown that the bioavailability of TiO2 NPs in gastrointestinal tract is very low and most of the ingested TiO2 NPs are excreted with feces [16,17,18,19], suggesting that after being orally ingested, most of the ingested TiO2 NPs would move through the gastrointestinal tract, making the gastrointestinal tract one of its main target organs. In vitro studies have revealed that TiO2 NPs exposure can directly damage intestinal epithelial microvilli and compromise the integrity of Caco-2 cell monolayer, including the intercellular connections [20, 21]. Our earlier in vivo research [22] also found that oral exposure to TiO2 NPs could downregulate the plasma D-lactate level and the activity of diamine oxidase (DAO), implicating its potential to affect intestinal permeability. Inflammation is an important mechanism for toxic effects caused by nanomaterials, including TiO2 NPs. Nogueira et al [23] set up a 10-day oral-exposure study and found that TiO2 NPs induced Th1 cells dominated inflammatory response in the small intestine, the ileum showed the most sever inflammatory response among all the segments of the small intestine. Inflammatory response is associated with downregulated expression of tight junction proteins [24,25,26,27,28], which may further increased epithelial permeability and health risks. Though it’s unclear yet whether TiO2 NPs would impair intestine barrier function by inducing inflammation or not. On the other hand, it’s easy for the ingested TiO2 NPs to engage with other substances in gut, like lipopolysaccharide (LPS) from bacteria. Several in vitro studies [29, 30] have already indicated co-exposure of TiO2 NPs and LPS may trigger severer inflammatory response, suggesting the potential of TiO2 NPs to interact with LPS and affect gut functions, but these findings still need to be verified in vivo.

So far, there is still limited number of in vivo studies over TiO2 NPs influencing intestinal functions, and most of them are confined to evaluating the capability of TiO2 NPs to cross the intestinal mucous membrane and accumulate in or impact on other organs [16, 31, 32]. Furthermore, these in vivo studies adopted oral gavage where TiO2 particles were suspended in liquid medium and administrated intensively, which is not in accordance with the experience of human where TiO2 particles are being ingested in milder ways, like multiple food or drug intakes. In addition, the dosage is usually high and the exposure time is usually short, with a maximum exposure period up to 90 days [17, 18, 31, 33, 34]. While the public typically have a low TiO2 NPs dosage and a long exposure period, so, the chronic toxicity profiles of TiO2 NPs still need to be supplemented.

For these considerations, we simulated human exposure scenarios by mixing TiO2 NPs into feeds and feeding it to mice for up to 6 months, aiming at exploring the chronic effect of TiO2 NPs on intestinal barrier. Furthermore, we attempted to verify whether long term exposure to TiO2 NPs would exacerbate the impact of bacterial toxins (Lipopolysaccharides, LPS) on intestine barrier.


Physiochemical properties of titanium dioxide

As shown in Fig. 1, the two TiO2 nanoparticles (TiO2 NPs and TiO2 MPs) both had the nearly spherical shape. TiO2 NPs was in anatase form and TiO2 MPs was in rutile form as tested by X-ray powder diffractometry (XRD). The purities were both over 99.95% (Impurity elements were presented in the Additional file 1: Table S1). The average primary diameters of TiO2 NPs and TiO2 MPs measured by transmission electron microscopy (TEM) were (33.6 ± 11.5) nm and (124.5 ± 46.1) nm respectively, and the Brunauer-Emmett-Teller (BET)-specific surface area were 61.87 m2/g and 9.35 m2/g respectively.

Fig. 1

TEM images, XRD images and TEM based size distributions of TiO2 NPs (a, c, e) and TiO2 MPs (b, d, f)

According to characterization of food additive TiO2 (E171) purchased from Chinese and European vendors, E171 was a mixture of micron-sized particles and nano-sized particles (NPs) with anatase, rutile, or anatase/rutile-mixed form [35]. The diameter of E171 ranged from 40 to 200 nm with 10–36% particles in nanoscale [1, 5, 36], which makes it difficult to explain whether the biological effects of E171 depends on its nano-fraction, micro-fraction, or the interaction of the two fractions. However, nano-fraction has attracted more attention since nanoparticles could exhibit completely different physiochemical properties as well as different biological impacts compared to their native bulk compounds. Hence, anatase TiO2 NPs and rutile TiO2 MPs which had relatively uniform particle sizes were used in this study to represent the different crystal components of food additive TiO2 E171 within nanoscale and help us to understand the health risk of nano-fraction of E171 [35].

Different from previous studies that dispersed TiO2 in ultrapure water for exposure via oral gavage, we mixed TiO2 into feed and fed it to mice for exposure. To compare the characteristic changes of the TiO2 particles ingested via oral gavage and via mixed feed in the gastrointestinal tract, the hydrodynamic diameters, polydispersity index (PDI), and zeta potential were tested carefully when the particles and particle-mixed feeds were dispersed or digested in ultrapure water (H2O), artificial gastric juice (AGJ) and artificial intestinal juice (AIJ). As shown in Table 1, both TiO2 would aggregate into larger particles in H2O, AGJ and AIJ, with the biggest hydrodynamic diameters and the worst dispersion stability in the AGJ. We also found the particles in feeds aggregated into the biggest particles in AGJ but the smallest particles in AIJ after the feeds were digested in AGJ for 2 h and further in AIJ for a 2.5 h. These results suggested that TiO2 ingested via the two exposure routes presented different physiochemical properties in the gastrointestinal tract, which would result in different biological effects.

Table 1 The dispersion state of TiO2 particles in ultrapure water, artificial gastric/intestinal juice (AGJ/AIJ)

Animal behavior, body weight and feed consumption

During the animal experimental period of 6 months, only one mouse in TiO2 NPs exposed groups showed anal swelling on the 43th day and died of intestinal obstruction two days later, all other mice showed no abnormality.

As shown in Fig. 2a, though with fluctuation, body weights of mice in either control, TiO2 NPs exposed group or TiO2 MPs exposed group continued to increase since exposure and remained stable from the 17th week onwards. No statistically significant differences in body weight were found between the control group, TiO2 NPs exposed group and TiO2 MPs exposed group during the exposure period of 6 months, except for the reduced body weight in TiO2 MPs exposed group by the end of the 2nd week when compared to control group.

Fig. 2

Change of body weight (a) and daily feed intake (b, c) in mice during exposure to TiO2 NPs or TiO2 MPs-mixed feed for 1, 3, and 6 months (mean ± SD). *: difference between TiO2 NP exposed group and control group is statistically significant, p< 0.05; #: difference between TiO2 NPs exposed group and TiO2 MPs exposed group is statistically significant, p< 0.05. n: number of mice per group in each period, as 4 mice were housed in one cage, n/4 data points (one data per cage) were included for sensitivity analysis

We observed notable change of daily feed intake in TiO2 NPs exposed group. Comparing to control group, daily feed intake of mice in TiO2 NPs exposed group decreased in the 7th, 14th, 16th and 18th week, while no significant change was observed in TiO2 MPs exposed group (Fig. 2b). We also found that daily feed intake of mice in TiO2 NPs exposed group is lower than that of TiO2 MPs exposed group in several interval weeks. When feed up to 6 months, the average daily feed intake per mouse in TiO2 NPs exposed group significantly reduced compared to control group and TiO2 MPs exposed group (Fig. 2c).

Bio-transport of ingested TiO2

During exposure, mice in both TiO2 exposed groups started excreting white feces from the 3rd week of exposure onwards (Fig. 3a), indicating that TiO2 were excreted via feces. Although TiO2 particles were observed in the intestinal epithelial cell cytoplasm in both TiO2 NPs and TiO2 MPs exposed groups (Fig. 3b, further introduced below), the increased Ti content in blood cells was only found in the TiO2 MPs exposed group after 6 months of exposure (Fig. 3c).

Fig. 3

The translocation of TiO2 particles from the gastrointestinal tract. (a) Fecal images of mice fed with control feed, 1% (w/w) TiO2 NPs or TiO2 MPs mixed feed for 21 days of exposure. Similar feces were observed from day 21 onwards (from day 21 to the end of exposure). (b) TEM images of ileum mucosa in mice after fed with TiO2 NPs or TiO2 MPs-mixed feed for 6 months. Red arrows indicate TiO2 particles internalized into intracellular vesicles. Blue arrows indicate microvilli. (c) Ti content in mice blood cells (μg/g dry weight) after feeding with control, 1% (w/w) TiO2 NPs or 1% (w/w) TiO2 MPs-mixed feed (mean ± SD, n=5) for up to 1, 3, 6 months

Intestinal permeability

Levels of serum LPS, D-lactate and DAO were detected to evaluate the permeability of the intestinal barrier. As shown in Fig. 4, significant changes were found in LPS and DAO but not in D-lactate. No differences were observed when comparing these indexes in TiO2 NPs or TiO2 MPs exposed groups with control groups. However, a significant decrease in serum DAO was found in the LPS exposed group in the 6th month (see exposure group in Table 2), lower DAO levels were found in (TiO2 NPs + LPS) exposed group at the 3rd and the 6th month, we also observed lower LPS and DAO levels in (TiO2 MPs + LPS) group at the 3rd month. The serum DAO level in (TiO2 NPs + LPS) exposed group was also notably lower than in TiO2 NPs exposed group at the 3rd and the 6th month. Through interaction analysis (Table 3), we only observed an antagonistic interaction between TiO2 MPs and LPS at the 6th month over serum DAO, no interaction was observed between TiO2 NPs and LPS over intestinal permeability.

Fig. 4

Change of intestinal permeability in mice after treatment with TiO2 and lipopolysaccharides (LPS). The levels of LPS (a), diamine oxidase (DAO) activity (b) and D-lactate (c) in mice serum after mice being fed with TiO2 NPs or TiO2 MPs-mixed feed for 1, 3, and 6 months and following gavage with LPS (mean ± SD, n =4). Significant differences between two groups (*p< 0.05, **p< 0.01)

Table 2 Animal grouping and treatment
Table 3 The interaction between TiO2 particles and LPS on mice

Collectively, TiO2 NPs or TiO2 MPs exposure did not influence intestinal permeability, LPS stimulation following TiO2 exposure reduced intestinal permeability.

Intestinal histopathological examination

In control group at each time interval, intestinal villi of duodenum, jejunum and ileum are all long and intact, the intestinal cells are well lined up, structures of intestinal crypts are clear, no hyperaemia, edema or inflammatory cell infiltration were observed in all the small intestine segments. No abnormality was observed in TiO2 NPs exposed group or TiO2 MPs exposed group except for increased eosinophil in both groups at the 1st, the 3rd and the 6th month (Fig. 5). LPS stimulation didn’t cause any noticeable changes as well.

Fig. 5

Histopathological examination of mice small intestine after treatment with TiO2 and lipopolysaccharides. Representative Figures are shown for each group, and three mice per group were included for histopathological assessment (n=3)

We also assessed the villi height/crypt depth ratio in different segments of the small intestine (Table 4). Compared with the control group, in the duodenum, the villi height/crypt depth ratio increased significantly after 1-month exposure to TiO2 NPs or TiO2 MPs as well as after LPS stimulation by the end of the 1st month, but the ratio decreased after LPS stimulation by the 3rd and the 6th month. In the jejunum, the villi height/crypt depth ratio increased after 1- and 3-month exposure to TiO2 MPs or (TiO2 NPs + LPS). In the ileum, the villi height/crypt depth ratio decreased after 1-month exposure to TiO2 NPs, (TiO2 MPs + LPS) and after LPS stimulation by the 1st month, but the ratio increased after 3-month exposure to TiO2 NPs or TiO2 MPs. In further interaction analysis (Table 3), we observed antagonistic interactions in villi height/crypt depth ratio between TiO2 NPs and LPS in the duodenum after 1-month exposure, in the jejunum after 3-months exposure, and in the ileum after 1-month and 3-months exposure. The interactions between TiO2 MPs and LPS over the villi height/crypt depth ratio in duodenum and jejunum were antagonistic effect after 1-month exposure but synergistic effect after 3-months exposure.

Collectively, exposure of TiO2 NPs and TiO2 MPs mostly increased the villi height/crypt depth ratio in the small intestine, but LPS stimulation mainly reduced the villi height/crypt depth ratio. Although increased jejunal villi height/crypt depth ratio presented in (TiO2 NPs + LPS) group, an antagonistic interaction was found between TiO2 NPs and LPS. Ileal villi height/crypt ratios decreased in (TiO2 MPs +LPS) group, the interaction between TiO2 MPs and LPS were antagonistic after 1-month exposure and synergistic after 3-month exposure. It should be noted that these effects on villi height/crypt depth ratios of the small intestine disappeared when the TiO2 exposure lasted for 6 months.

Table 4 Villi height/ crypt depth ratio in the small intestine after treatment with TiO2 and LPS

Intestinal epithelial ultrastructure and expression of tight junction proteins

Among the 6-months-fed groups, the ultrastructures of ileal epithelial of control group, TiO2 NPs exposed group and TiO2 MPs exposed group were assessed (Fig. 3b). Some spherical shaped particles with diameter of (48.5 ± 13.9) nm and (84.9 ± 16.0) nm were observed in the epithelial cell cytoplasm in TiO2 NPs and TiO2 MPs exposed groups respectively (Fig. 3b), which parallel the shape and size of TiO2 NPs and TiO2 MPs being used in this study therefore it’s high likely that these observed particles are TiO2 particles. Comparing to control group, height and density of microvilli were reduced in TiO2 MPs exposed group while not in TiO2 NPs exposed group. No other ultrastructural changes were observed in both TiO2 exposed group.

We examined expression of tight junction proteins in ileal epithelial. As indicated in Fig. 6, 1-month exposure to TiO2 NPs notably increased occludin expression. Exposure to TiO2 MPs, (TiO2 NPs + LPS) and (TiO2 MPs + LPS) upregulated expression of ZO-1 at the 1st month, and (TiO2 MPs + LPS) exposure continued to upregulate ileal ZO-1 level significantly at the 6th month. We observed an antagonistic effect between TiO2 NPs and LPS over the expression of ileal occludin by the 1st month, however, such interaction disappeared by the 3rd and 6th month (Table 3).

Fig. 6

Tight junction proteins in mice ileum tissues. Levels of ZO-1 and occludin in mice ileum tissues after mice being fed with control feed, TiO2 NPs-mixed feed or TiO2 MPs-mixed feed for 1, 3, 6 months and following gavage with or without 10 mg/kg LPS (mean ± SD, n =3). Significant differences between two groups (* P< 0.05). 1 M: 1 month; 3 M: 3 months; 6 M: 6 months

Inflammatory biomarker in ileum and serum

In ileum tissues, levels of IL-1β, IL-6, IL-10, IL-13, TNF-α and IFN-γ in both TiO2 NPs and TiO2 MPs exposed groups remained similar as control group (Fig. 7 A1-A18). After stimulation with LPS, ileal IL-1β levels in LPS group and (TiO2 NPs + LPS) exposed group at the 1st month were significantly lower than in control group, while no difference was observed between LPS and (TiO2 NPs + LPS) group. We didn’t observe any interaction between both TiO2 and LPS over these ileal cytokine levels (Table 3).

Fig. 7

Inflammatory cytokines in mice ileum tissues and serum. Levels of IL-1β, IL-6, IL-10, IL-13, IFN-γ, TNF-α in mice ileum(A1-A18) and serum (B1-B18) after being fed with TiO2 NPs or TiO2 MPs-mixed feed for 1, 3, 6 months and following gavage with or without LPS (mean ± SD, n =4). Significant differences between two groups (*p< 0.05)

Serum inflammatory biomarkers were also not seen change notably (Fig. 7 B1-B18). Comparing to control group, serum IL-1β level was significantly lower in TiO2 MPs exposed group at the 3rd month and in TiO2 NPs exposed group at the 6th month, serum IL-6 level in TiO2 MPs exposed group notably dropped at the 6th month. After stimulation with LPS, LPS group displayed higher serum TNF-α levels than control group at the 6th month, but the cytokine levels of (TiO2 NPs + LPS) and (TiO2 MPs + LPS) groups were still similar to control group at all time points. By the 6th month, we observed an antagonistic interaction of TiO2 NPs and LPS over serum IL-1β levels (Table 3).


The highlights of this study are that TiO2 was mixed into feed and fed to mice for up to 6 months for exposure. Such exposure method was subtle and avoided any potential stimuli associated with oral gavage that has been used in most in vivo studies. In the meanwhile, the exposure method is more comparable to actual exposure that human experiences, where TiO2 particles are often been ingested along with food. Moreover, rodents are nocturnal and most activities happens during the night, including feeding, our exposure method guaranteed the TiO2 were ingested via daily activities, other exposure methods like oral gavage which often happens during the daytime fail to capture this. Hence, the research is valuable for evaluating the safety of food additive TiO2. Moreover, this is the first study to extend in vivo exposure of TiO2 particles to 6 months and reveal the minor biological impacts of TiO2 following chronic exposure by studying its translocation from intestine, impacting on intestinal barrier, pro-inflammation potency and its potential to interact with LPS in gut.

Translocation of TiO2 NPs and TiO2 MPs from gut and animal behavior

In this study, ingesting TiO2 NPs-mixed or TiO2 MPs-mixed feed for 6 months did not influence body weight of the mice, but TiO2 NPs exposure notably decreased the feed intake. The possible explanation is that the exposure time is not long enough for the decreased feed intake influence body weight or the physical activity of mice were reduced after TiO2 exposure. It’s a pity were cannot verify as we have no activity data available. The low feed intake might lead to malnutrition and increased health risks in the long run, and more attention should be paid to its long-term impact on nutrition imbalance in further studies. Our previous study identified TiO2 NPs of small sizes could affect nutrient absorption and metabolism by inducing intestinal epithelial injury, with amino acids more susceptible than metal elements and glucose [37]. However, after 6-months of exposure to TiO2 in this study, no notable histopathological changes were found in the small intestine of mice, including the intestinal villi height/crypt depth ratio. It seems the intestinal nutrient absorption wasn’t increased by TiO2 NPs exposure. Hence, the low feed intake of TiO2 NPs exposed group might result in energy and nutrient deficiency, leading to malnutrition and other diseases. More researches are still needed for verification in the future.

As frequently reported, TiO2 particles had a very low bioavailability in both in vitro and in vivo studies [16, 18, 38, 39]. In both TiO2 NPs exposed group and TiO2 MPs exposed group, the Ti contents in blood cells were found to be low and are of similar concentration as control group, except for the increased Ti content at the 6th month in TiO2 MPs exposed group. And the Ti content also didn’t increased significantly in liver, kidney and spleen [40]. These results suggest the bioavailability of TiO2 was low and most of the TiO2 particles might be excreted with feces, which are in accordance with the excretion of white feces we observed. TiO2 particles were white pigment and the feces were easily whitened by these TiO2 particles when they are excreted with feces.

It’s well known that the particles with smaller size could be transported through the biological barriers easier than these with larger sizes, hence the low bioavailability could be partially explained by the agglomeration of TiO2 particles in the gastrointestinal tract as shown in Table 1. Once being ingested, TiO2 particles will move through various digestive juices, including saliva, gastric and intestinal juices. The local biomolecules within these digestive juices, feed components as well as intestinal flora products like LPS may coat onto the surface of TiO2 particles and form protein corona, which may substantially change physiochemical properties of TiO2 particles and influence its bioavailability [41, 42]. Sinnecker [43] also reported that luminal gut-constituents may both attenuate and augment the adherence of nanoparticles to cell surface, the process of which is particle size-dependent and interacting biomolecular dependent. In addition, as reported in a recent research [44], the limited Ti translocation could also be explained by the presence of intestinal mucus which can trap food-grade TiO2 particles.

Effect of TiO2 NPs and TiO2 MPs on intestinal barrier function

Intestinal barrier function mainly relies on the integrity of the intestinal epithelial cell barrier, which is composed of intestinal epithelial cells and intercellular tight junctions [15]. Thus, we checked the intestinal epithelial histological structure and ultrastructure, the expression of tight junction proteins and the intestinal permeability in this study.

Based on the observations (as summarized in Table 5), both TiO2 increased villi height/crypt depth ratio in the small intestine at the 1 and 3 months without causing histological injuries. Sparse and short microvilli were found in TiO2 MPs exposed group at the 6th months. Studies [45,46,47] have shown that a decreased villi height/crypt depth ratio or a reduced villi surface area is considered deleterious for digestion and absorption and could result in retarded growth, conversely, an increased villi height-to-crypt depth ratio as well as an increased villi surface area could promote the intestinal digestion-absorption function. The sparse and short microvilli would reduce the villi surface area and result in decreased intestinal digestive and absorptive capacity. As microvilli structure remain unaffected in TiO2 NPs exposed group, it may indicate that TiO2 NPs increased intestinal digestion and absorption area by increasing villi height/crypt ratio, which may help explain the reduced feed consumption as discussed above. Similar results were reported by Ammendolia et al [48] where TiO2 NPs increased jejunal villi height/crypt ratio without damaging intestinal mucosa epithelium. In TiO2 MPs exposed group, though increased villi height/crypt depth ratios were observed at the 1 and 3 months, severely reduced microvilli height and density in intestinal columnar epithelium were observed at the 6 months. It suggested long time exposure to TiO2 MPs would cause intestinal injury, which would contribute to the increased Ti content in blood cells after 6 months exposure to TiO2 MPs since more particles would translocate through the damaged intestinal epithelial. Moreover, there is one study [49] showed that exposure to food-grade TiO2 (E171) for 100 days in rats triggered low-grade inflammation and initiated preneoplastic lesions in colon featuring increased number of aberrant crypts, and increased number of large aberrant crypt foci at the colonic mucosal surface. Although it remains unclear whether the increased villi height/crypt depth ratio we observe might also associate with the health risks of intestinal villus hyperplasia and carcinogenesis, more attention should be paid to the long-term effects of TiO2 exposure along with these changes.

Table 5 Notable changes of biological parameters in mice after treatment with TiO2 and LPS

Tight junction plays an important role in maintaining the integrity of intestinal epithelial barrier and intestinal permeability. A recent in vitro study [50] reported that TiO2 NPs upregulated ZO-1, occludin and claudin-2 expression in a shape- and time-dependent manner in an in vitro model (Caco-2/HT29) of the intestinal barrier. In the current study, increased ZO-1 and occludin are only observed in the 1st month, which make it difficult for us to conclude our results parallel the in vitro findings, such uncertainly is further supported by the absence of reduced intestinal permeability (no notable changes in serum DAO activity, LPS and D-lactate levels suggest no notable change of intestinal permeability) since upregulated tight junction protein would lead to decreased intestinal permeability. It is also inconsistent with our earlier research [22] where we observed declined serum DAO activity and D-lactate content after continuous gavage of 200 mg/kg TiO2 NPs (TEM measured size: 75 ± 15 nm; BET specific surface area: 63.95 m2/g) to adult SD rats for 30 days, which indicates decreased intestinal mucosal permeability. These differences may originate from the differences in animal species, exposure methods, exposure time length and the physiochemical properties of the TiO2 particles used.

Inflammatory response induced by TiO2 NPs and TiO2 MPs

The intestinal immunity is an important part of systemic immunity and regulates the function of intestinal epithelial tight junction. In the present study, we analyzed five proinflammatory cytokines (IL-1β, IL-6, IL-13, TNF-α, and IFN-γ) and one anti-inflammatory cytokine (IL-10). Briefly, IL-1β, TNF-α, IFN-γ can impact on MLCK and eventually increase tight junction permeability. IL-6 is capable of inducing immune cell differentiation and plays a proinflammatory role which includes promoting T cells to differentiate into Th17 cells. IL-17, secreted by Th17 cells, and IL-13 can both upregulate claudin-2 concentration, which in turn increases intercellular pore channel permeability, thus increasing the permeability of the intestinal barrier. Anti-inflammatory cytokine IL-10 however inhibits the differentiation of Th1 cells, enabling it to play an anti-inflammatory role in the intestinal tract, thereby maintaining the homeostasis of barrier permeability.

Exposure to TiO2 NPs or TiO2 MPs for up to 1, 3, 6 months has not increased serum nor ileal cytokine levels, suggesting that TiO2 NPs or TiO2 MPs exposure did not cause notable inflammation. Nogueira et al [23] tested the potential of TiO2 to induce intestinal inflammation in Bl57/6 mice, they found that TiO2 NPs can increase cytokine IL - 4, IL - 12, IL - 23, TNF-α, IFN-γ, TGF-β levels in duodenum, jejunum and ileum, of which the ileum showed the highest level of cytokine. These different observations might be explained from several aspects. First, we used different TiO2 particles, the differences in physiochemical properties may result in different affinity to biomolecules and feed components, which may lead to different surface coating of these particle and different biological effects. Second, the mild reactions found in this study might attribute to the exposure method we used which avoided addition stress accompanied by gavage, and won’t lead to intensive TiO2 exposure in just seconds. Third, the dosage and the length of exposure were different. Last, the animal model we used in current study, the outbred ICR mice, is less sensitive to subtle stimuli, which is also an important reason for the different observations.

Combined effect of TiO2 NPs and TiO2 MPs with LPS

After LPS stimulation, we observed increased expression of tight junction protein ZO-1 and declined serum DAO activity in (TiO2 NPs + LPS) exposed group and (TiO2 MPs + LPS) exposed group when compared to the TiO2 NPs exposed group and TiO2 MPs exposed group respectively, implying that co-exposure of TiO2 and LPS reduced the permeability of the intestinal barrier. The intestinal villi height/crypt depth ratio was also found after co-exposure of TiP2 and LPS. However, cytokines were not seen notably increased in (TiO2 NPs + LPS) and (TiO2 + LPS) treatment groups. The antagonistic effects were mostly found between TiO2 NPs and LPS.

The interaction between TiO2 and LPS have been reported in several studies. Riedle S et al [51] reported that the cell viability of bone marrow-derived macrophages was unaffected when TiO2 particles were applied after LPS exposure, but TiO2 particles could augmented LPS induced inflammation, Bianchi et al [52] found that compared to sole-exposure of LPS or TiO2 NPs, strengthened and more persistent inflammation in RAW264.7 cells were observed when LPS adsorbed onto nano-TiO2 protein corona. It is clear that these in vitro studies indicated synergistic effects between TiO2 NPs and LPS. Our recent work [53] found that TiO2 NPs could modify gut microbiota community structure and mitigate TNBS induced colitis. These contradictory findings may be well caused by the differences between in vitro and in vivo system, the different findings may also lie in the differences between physiochemical properties of TiO2 particle as well as the differences in dosage. In addition, TiO2 NPs are usually applied together with LPS in in vitro studies, while in the current study, mice were fasted for 6 h before LPS administration, and as mice is nocturnal rodent, LPS was administered during the non-active phase of the mice. For more clarity, more researches are still needed.


This study found that short-term and long-term ingesting TiO2 NPs and TiO2 MPs-mixed feed would alter intestinal villi structure without impairing intestinal barrier function, however, co-exposure of TiO2 NPs or TiO2 MPs and LPs would enhance intestinal barrier function without causing notable inflammatory responses. In addition, TiO2 NPs showed antagonistic effect with LPS over intestinal villi height/crypt depth ratio. The gentle exposure method (i.e. feeding TiO2 mixed feeds) might have contributed to the mild chronic biological effects of TiO2 NPs observed in the current study. Since ingested TiO2 via mixed feed and via oral gavage could present different physiochemical properties in gastrointestinal tract which would in turn result in different biological effects, and as ingesting TiO2 with feed represents the exposure route of human being, the current research is very valuable for evaluating the safety of food additive TiO2 and more attention should be paid to exploring the biological effects of TiO2 NPs under realistic exposure conditions. Considering that TiO2 is a suspected carcinogen and might associate with the increased risk for the formation of colonic carcinoma, more researches are needed for clarifying whether the histological changes of intestinal villi and crypts associate with hyperplasia and carcinogenesis or not. In addition, there is a large number of bacteria exist in the intestine, among which Gram-negative bacteria produce LPS, the continuous effect of the combined exposure of TiO2 and LPS should attract attention.


Physiochemical characterization of TiO2 particles

Two food-grade TiO2 particles were purchased from Shanghai Yunfu Nanotechnology Co. Ltd., China. The primary size and shape of both TiO2 particles were determined using a transmission electron microscopy (TEM, JEM-2100F, JEOL, Japan). The crystal structures of both TiO2 were assessed with an X-ray powder diffractometry (XRD, X’Pert Pro, PANalytical). The specific surface areas were assessed based on Brunauer–Emmett–Teller (BET) method (Autosorb-iQ2-MP, Malvern Panalytical). The purity and impurities were analyzed with an inductively coupled plasma mass spectrometry (ICP-MS, Thermo Elemental X7, Thermo Electron Corporation).

Artificial gastric juice (AGJ) and artificial intestinal juice (AIJ) were prepared as described in our earlier study [22]. Briefly, the AGJ (pH=1.2) was prepared with 10 g/L pepsin (3800 units/mg) and 45 mmol/L HCl. The AIJ (pH=6.8) was constituted by 10 g/L trypsin and 6.8 g/L KH2PO4. Both TiO2 particles were suspended in ultrapure water, AGJ or AIJ respectively and were ultrasonicated for 30 min before measuring its hydrodynamic diameter, polydispersity index values (PDI) and Zeta-potential using a ZetaSizer Nano ZS90 (Malvern Instruments Ltd., Malvern, UK).

Feed preparation and characterization

The commercial pellet diet and two kinds of TiO2-mixed feeds were supplied by Beijing Ke Ao Xie Li Food Co. Ltd., China. The TiO2-mixed feeds were produced by mixing 1% (mass fraction) TiO2 NPs or TiO2 MPs into the commercial pellet diet. This dosage was selected based on the maximum usage of TiO2 allowed in food, where both the U.S. Food & Drug Administration and the national food safety criteria of China (GB 2760–2014) have regulated TiO2 usage in food should be no more than 1% of the total weight.

TiO2 NPs or TiO2 MPs-mixed feed was digested in AGJ for 2 h firstly, and then moved into AIJ for further digestion of 2.5 h. The above experiment was conducted on a horizontal shaker to mimic feed digestion in vivo. After digestion, the suspensions were collected and ultrasonicated for 30 min to break up aggregates. The particle hydrodynamic diameter, PDI and Zeta-potential were assessed using ZetaSizer Nano ZS90.

Animal treatment

The healthy male ICR mice of 3-week old were bred and supplied by the Department of Laboratory Animal Science, Peking University Health Science Center. The animals were fed a sterilized commercial pellet diet and deionized water ad libitum, and were housed in plastic cages in a 20 ±2 °C and 50–70% relative humidity room with a 12:12 h light-dark cycle. The animal experiments were carried out in accordance with the Guiding Principles in the Use of Animals in Toxicology adopted by Society of Toxicology and the European Union Directive 2010/63/EU for animal experiments and received approval from the Peking University Institutional Review Board (LA2019216).

After five days of acclimation, the 108 mice were randomly divided into 18 groups, 6 mice per group. As shown in Table 2, the mice were given normal feed, TiO2 NPs-mixed feed or TiO2 MPs-mixed feed respectively for up to 1, 3, 6 months, fasted for 6 h and followed by intragastric administration (ig) of 10 mg/(kg body weight) lipopolysaccharides (LPS, E.coli O111:B4, Sigma Aldrich) or same amount of deionized water. Additional LPS administration was performed to stimulate a flora disruption in the intestine and to investigate whether TiO2 exposure would alter the ability of the intestinal barrier to resist LPS invasion. Four hours later, the animals were anesthetized by ether, blood samples were collected from the eye artery by removing the eyeball quickly, the animals were then sacrificed. Sera were harvested by centrifuging blood samples at 3000 rpm for 10 min at 4 °C and the blood cells were kept for analyzing titanium (Ti) content. The tissues and organs including the small intestine were excised and stored in − 80 °C. During the whole experiment, four mice were housed together in a same cage, the animal behaviors, symptoms and mortality were recorded daily. The body weights and feed intake were measured weekly, and daily feed intake per mouse for each week was calculated. For calculating feed intake for longer period (like 1, 3, 6 months we reported), the daily feed intake is calculated as cumulative feed intake of the cage within the period being divided by the number of mice in the cage and the number of days of the period. For sensitivity analysis, each cage represents a data point of four mice, therefore, for the 1st month, we have 27 cages available (108 mice), representing 9 daily feed intake per group (9 cage * 3 types of feed). For the 3rd month, we have 18 cages (6 cages *3 types of feed), and 9 cages for the 6th month (3 cages*3 types of feed). The equations are shown below.

$$ \mathrm{Daily}\ \mathrm{feed}\ \mathrm{intake}\ \mathrm{for}\ \mathrm{each}\ \mathrm{week}=\mathrm{weekly}\ \mathrm{feed}\ \mathrm{intake}\ \mathrm{per}\ \mathrm{cage}/\left(7\ast \mathrm{number}\ \mathrm{of}\ \mathrm{mice}\right) $$

The daily feed intake per mouse for each period (1, 3, 6 months) was calculated as:

$$ \mathrm{Daily}\ \mathrm{feed}\ \mathrm{intake}=\mathrm{accumulative}\ \mathrm{feed}\ \mathrm{intake}\ \mathrm{per}\ \mathrm{cage}/\left(\mathrm{number}\ \mathrm{of}\ \mathrm{days}\ast \mathrm{number}\ \mathrm{of}\ \mathrm{mice}\right) $$

Intestinal permeability assessment

The permeability of the intestinal barrier was evaluated by detecting the levels of lipopolysaccharides (LPS) and D-lactate and the activity of diamine oxidase (DAO) in serum. Four samples from each group were randomly chosen for these tests. The LPS content was measured using the ToxinSensor™ Chromogenic LAL Endotoxin Assay Kit (GenScript, USA). The D-lactate level was determined by the colorimetric method according to the manufacturer’s protocol (D-lactate Assay Kit, BioVision, USA). The DAO activity was assessed by the reaction of cadaverine dihydrochloride (Sigma, USA) as described in our previous work [22].

Histopathological and TEM observation of gut tissues

For pathological assessment, all histopathological examinations were performed following a standard laboratory procedure. The intestinal tissues (three samples per group) were opened longitudinally and fixed in 10% formalin and embedded in paraffin blocks, from which 5 μm thick samples were sliced and placed onto glass slides. The slices were stained with hematoxylin and eosin (HE), an optical microscope was used to observe and take pictures. The identity of the slides was blinded to the pathologist. Five intact villi were randomly chosen from each slide if available, the villi height and the crypt depth were measured in duodenum, jejunum and ileum to calculate the ratio of the villi height to the crypt depth, resulting in 15 intact villi being examined per group from the three slides. In case of intact villi are insufficient, five intact villi were counted for the group from the three slides.

For TEM observation, the ileal mucosa samples from control, TiO2 NPs and TiO2 MPs group (one sample per group by the 6th month) were cut into small pieces (surface area = 1*1 mm2) and immediately fixed in 2.5% glutaraldehyde (pH=7.4) overnight. Then the samples were treated according to general protocols for TEM examination. The ultra-thin sections (70–100 nm) were stained with lead citrate and uranyl acetate and then were examined using a transmission electron microscopy (TEM, JEM-1400, JEOL, Japan).

Titanium content analysis

The blood cells were taken out and thawed (five samples per group).All the samples were freeze-dried in a freeze dryer (FD-1, Beijing Detianyou Technology Development Co., Ltd) with apparatus at − 50 °C and a pressure of 1.0 Pa for 24 h, these samples weighed between 0.03–0.18 g after drying. The freeze-dried samples were digested in 2 mL nitric acid and 0.5 ml H2O2 overnight. After adding 1 mL HF, the mixed solutions were heated at about 160 °C using high-pressure reaction container in an oven chamber until the samples were completely digested. Then, the solutions were heated at 120 °C to remove the remaining nitric acid until the solutions were colorless and clear. At last, the remaining solutions were diluted to 5 mL with 2% nitric acid and then were loaded onto an ICP-MS (NexION 300D, PerkinElmer) to analyze Ti concentration in the samples. The detection limit of Ti was 1.1 μg/g. Concentrations of Ti element were expressed as milligrams per gram dried weight.

Western blot analysis

The ileum tissue samples (three samples per group) were lysed in radioimmunoprecipitation assay buffer (RIPA buffer) supplemented with a cocktail of protease inhibitors. Then the proteins were collected after centrifugation and quantified using a Bradford protein assay kit (Beyotime Biotechnology, China). Equal amount of protein was denatured and separated on 7–12% SDS-PAGE gels and then transferred to nitrocellulose membrane (Merckmillipore). The membranes were blocked with 5% skimmed milk, subsequently incubated with primary antibodies against ZO-1 (1:2000, Abcam), occludin (1:20000, Abcam), and β-actin (1:30000) overnight at 4 °C, and then incubated with secondary antibody for 2 h at room temperature. The protein bands were detected by Western Blotting Luminol Reagent (Absin Bioscience Inc., China) and recorded on Kodak films (Eastman Kodak Company, US). Relative band densities of the various proteins were measured from scanned films using Image J Software.

Inflammatory cytokine analysis

The concentrations of six cytokine biomarkers in sera and the ileum tissues (four samples per group) were analyzed using Milliplex Map Kit (Cat. No. MTH17MAG-47 K, Merck Millipore, USA) following the manufacturer’s instructions. Briefly, the ileum tissues were homogenized in PBS buffer containing the protease inhibitors, then the supernatant was obtained after centrifugation. The tissue supernatants and sera samples, buffers, and cytokine standards were added into 96-well assay plates and incubated overnight at 4 °C with fluorescently labeled antibodies-coated beads which can capture IL-1β, IL-6, IL-10, IL-13, TNF-α, and IFN-γ. After further incubation with biotin-labelled detection antibodies and streptavidin-phycoerythrin conjugate, the beads were detected on a MAGPIX® multiplexing instrument (Luminex Corporation, USA). The xPONENT 4.1 software was used for data acquisition, with the calibration curve for each cytokine generated with a five-parameter logistic fit. The detection limits for the cytokine assays were 1 pg/mL.

Statistical analysis

SPSS 20.0 was used to carry out the statistical analysis. Data exhibited a normal distribution according to the K-S test were expressed as mean ± standard deviation (SD). Independent-samples T test was used to assess the significant difference between two experimental groups. One-way variance (ANOVA) with LSD-t or Dunnett’s T3 tests was applied to evaluate the statistical significance of the differences between the experimental groups and the controls. The interaction between TiO2 and LPS were analyzed based on 2 × 2 factorial design analysis. A p value less than 0.05 was considered statistically significant.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.



transmission electron microscopy


X-ray powder diffractometry




inductively coupled plasma mass spectrometry


artificial gastric juice


artificial intestinal juice


polydispersity index value




diamine oxidase


hematoxylin and eosin


  1. 1.

    Peters RJ, van Bemmel G, Herrera-Rivera Z, Helsper HP, Marvin HJ, Weigel S, et al. Characterization of titanium dioxide nanoparticles in food products: analytical methods to define nanoparticles. J Agric Food Chem. 2014;62(27):6285–93.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  2. 2.

    Lomer MCE, Hutchinson C, Volkert S, Greenfield SM, Catterall A, Thompson RPH, et al. Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn's disease. Brit J Nutr. 2004;92(6):947–55.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  3. 3.

    Food, Ministry Of Agriculture Fisheries. Dietary intake of food additive in the UK: Initial surveillance (Food surveillance paper no.37). 1st ed. London: H.M. Stationery Office1993.

  4. 4.

    Yang Y, Doudrick K, Bi X, Hristovski K, Herckes P, Westerhoff P, et al. Characterization of food-grade titanium dioxide: the presence of nanosized particles. Environ Sci Technol. 2014;48(11):6391–400.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  5. 5.

    Weir A, Westerhoff P, Fabricius L, Hristovski K, von Goetz N. Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol. 2012;46(4):2242–50.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    Chen XX, Cheng B, Yang YX, Cao AN, Liu JH, Du LJ, et al. Characterization and preliminary toxicity assay of Nano-titanium dioxide additive in sugar-coated chewing gum. Small. 2013;9(9–10):1765–74.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  7. 7.

    Farquhar MG, Palade GE. Junctional complexes in various epithelia. J Cell Biol. 1963;17(2):375–412.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  8. 8.

    Raleigh DR, Boe DM, Yu D, Weber CR, Marchiando AM, Bradford EM, et al. Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function. J Cell Biol. 2011;193(3):565–82.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  9. 9.

    Shen L, Weber CR, Raleigh DR, Yu D, Turner JR. Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol. 2011;73:283–309.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  10. 10.

    Van Itallie CM, Fanning AS, Bridges A, Anderson JM. ZO-1 stabilizes the tight junction solute barrier through coupling to the Perijunctional cytoskeleton. Mol Biol Cell. 2009;20(17):3930–40.

    PubMed  PubMed Central  Article  Google Scholar 

  11. 11.

    Suzuki T, Yoshinaga N, Tanabe S. Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J Biol Chem. 2011;286(36):31263–71.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  12. 12.

    Buschmann MM, Shen L, Rajapakse H, Raleigh DR, Wang Y, Wang Y, et al. Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux. Mol Biol Cell. 2013;24(19):3056–68.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    Wisner DM, Harris LR, Green CL, Poritz LS. Opposing regulation of the tight junction protein claudin-2 by interferon-gamma and interleukin-4. J Surg Res. 2008;144(1):1–7.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  14. 14.

    Mankertz J, Amasheh M, Krug SM, Fromm A, Amasheh S, Hillenbrand B, et al. TNFalpha up-regulates claudin-2 expression in epithelial HT-29/B6 cells via phosphatidylinositol-3-kinase signaling. Cell Tissue Res. 2009;336(1):67–77.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  15. 15.

    Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9(11):799–809.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  16. 16.

    MacNicoll A, Kelly M, Aksoy H, Kramer E, Bouwmeester H, Chaudhry Q. A study of the uptake and biodistribution of nano-titanium dioxide using in vitro and in vivo models of oral intake. J Nanopart Res. 2015;17(2).

  17. 17.

    Wang J, Zhou G, Chen C, Yu H, Wang T, Ma Y, et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett. 2007;168(2):176–85.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  18. 18.

    Cho WS, Kang BC, Lee JK, Jeong J, Che JH, Seok SH. Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part Fibre Toxicol. 2013;10:9.

  19. 19.

    Onishchenko GE, Erokhina MV, Abramchuk SS, Shaitan KV, Raspopov RV, Smirnova VV, et al. Effects of Titanium Dioxide Nanoparticles on Small Intestinal Mucosa in Rats. B Exp Biol Med+. 2012;154(2):265–70.

  20. 20.

    Faust JJ, Doudrick K, Yang Y, Westerhoff P, Capco DG. Food grade titanium dioxide disrupts intestinal brush border microvilli in vitro independent of sedimentation. Cell Biol Toxicol. 2014;30(3):169–88.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  21. 21.

    Koeneman BA, Zhang Y, Westerhoff P, Chen YS, Crittenden JC, Capco DG. Toxicity and cellular responses of intestinal cells exposed to titanium dioxide. Cell Biol Toxicol. 2010;26(3):225–38.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  22. 22.

    Wang Y, Chen Z, Ba T, Pu J, Chen T, Song Y, et al. Susceptibility of young and adult rats to the oral toxicity of titanium dioxide nanoparticles. Small. 2013;9(9–10):1742–52.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  23. 23.

    Nogueira CM, de Azevedo WM, Dagli ML, Toma SH, Leite AZ, Lordello ML, et al. Titanium dioxide induced inflammation in the small intestine. World J Gastroenterol. 2012;18(34):4729–35.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  24. 24.

    Clayburgh DR, Musch MW, Leitges M, Fu YX, Turner JR. Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J Clin Invest. 2006;116(10):2682–94.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  25. 25.

    Clayburgh DR, Barrett TA, Tang YM, Meddings JB, Van Eldik LJ, Watterson DM, et al. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest. 2005;115(10):2702–15.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  26. 26.

    Wang FJ, Graham WV, Wang YM, Witkowski ED, Schwarz BT, Turner JR. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol. 2005;166(2):409–19.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  27. 27.

    Utech M, Ivanov AI, Samarin SN, Bruewer M, Turner JR, Mrsny RJ, et al. Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell. 2005;16(10):5040–52.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  28. 28.

    Al-Sadi R, Ye D, Dokladny K, Ma TY. Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J Immunol. 2008;180(8):5653–61.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  29. 29.

    Powell JJ, Harvey RS, Ashwood P, Wolstencroft R, Gershwin ME, Thompson RP. Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. J Autoimmun. 2000;14(1):99–105.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  30. 30.

    Huang C, Sun MY, Yang Y, Wang F, Ma XQ, Li JQ, et al. Titanium dioxide nanoparticles prime a specific activation state of macrophages. Nanotoxicology. 2017;11(6):737–50.

    PubMed  PubMed Central  Google Scholar 

  31. 31.

    Duan YM, Liu J, Ma LL, Li N, Liu HT, Wang J, et al. Toxicological characteristics of nanoparticulate anatase titanium dioxide in mice. Biomaterials. 2010;31(5):894–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  32. 32.

    Hu HL, Guo Q, Wang CL, Ma X, He HJ, Oh YR, et al. Titanium dioxide nanoparticles increase plasma glucose via reactive oxygen species-induced insulin resistance in mice. J Appl Toxicol. 2015;35(10):1122–32.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  33. 33.

    Chen ZJ, Wang Y, Ba T, Li Y, Pu J, Chen T, et al. Genotoxic evaluation of titanium dioxide nanoparticles in vivo and in vitro. Toxicol Lett. 2014;226(3):314–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  34. 34.

    Chen Z, Wang Y, Zhuo L, Chen S, Zhao L, Chen T, Li Y, Zhang W, Gao X, Li P, Wang H, Jia G. Interaction of titanium dioxide nanoparticles with glucose on young rats after oral administration. Nanomedicine. 2015;11(7):1633–42.

  35. 35.

    Rodriguez-Escamilla JC, Medina-Reyes EI, Rodriguez-Ibarra C, Deciga-Alcaraz A, Flores-Flores JO, Ganem-Rondero A, et al. Food-grade titanium dioxide (E171) by solid or liquid matrix administration induces inflammation, germ cells sloughing in seminiferous tubules and blood-testis barrier disruption in mice. J Appl Toxicol. 2019;39(11):1586–605.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  36. 36.

    Dorier M, Beal D, Marie-Desvergne C, Dubosson M, Barreau F, Houdeau E, et al. Continuous in vitro exposure of intestinal epithelial cells to E171 food additive causes oxidative stress, inducing oxidation of DNA bases but no endoplasmic reticulum stress. Nanotoxicology. 2017;11(6):751–61.

  37. 37.

    Gao Y, Ye Y, Wang J, Zhang H, Wu Y, Wang Y, et al. Effects of titanium dioxide nanoparticles on nutrient absorption and metabolism in rats: distinguishing the susceptibility of amino acids, metal elements, and glucose. Nanotoxicology. 2020;14(10):1301–23.

  38. 38.

    Song ZM, Chen N, Liu JH, Tang H, Deng X, Xi WS, et al. Biological effect of food additive titanium dioxide nanoparticles on intestine: an in vitro study. J Appl Toxicol. 2015;35(10):1169–78.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  39. 39.

    Vila L, Garcia-Rodriguez A, Marcos R, Hernandez A. Titanium dioxide nanoparticles translocate through differentiated Caco-2 cell monolayers, without disrupting the barrier functionality or inducing genotoxic damage. J Appl Toxicol. 2018;38(9):1195–205.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  40. 40.

    Duan S-M, Zhang Y-L, Gao Y-J, Lv L-Z, Wang Y. The influence of long-term dietary intake of titanium dioxide particles on elemental homeostasis and tissue structure of mouse organs. J Nanosci Nanotechnol. in press.

  41. 41.

    Shakiba S, Hakimian A, Barco LR, Louie SM. Dynamic intermolecular interactions control adsorption from mixtures of natural organic matter and protein onto titanium dioxide nanoparticles. Environ Sci Technol. 2018;52(24):14158–68.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  42. 42.

    Barbero F, Russo L, Vitali M, Piella J, Salvo I, Borrajo ML, et al. Formation of the protein Corona: the Interface between nanoparticles and the immune system. Semin Immunol. 2017;34(C):52–60.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  43. 43.

    Sinnecker H, Ramaker K, Frey A. Coating with luminal gut-constituents alters adherence of nanoparticles to intestinal epithelial cells. Beilstein J Nanotechnol. 2014;5:2308–15.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  44. 44.

    Talbot P, Radziwill-Bienkowska JM, Kamphuis JBJ, Steenkeste K, Bettini S, Robert V, et al. Food-grade TiO2 is trapped by intestinal mucus in vitro but does not impair mucin O-glycosylation and short-chain fatty acid synthesis in vivo: implications for gut barrier protection. J Nanobiotechnol. 2018;16(1):53.

  45. 45.

    van Wettere WHEJ, Willson NL, Pain SJ, Forder REA. Effect of oral polyamine supplementation pre-weaning on piglet growth and intestinal characteristics. Animal. 2016;10(10):1655–9.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  46. 46.

    Moeser AJ, Ryan KA, Nighot PK, Blikslager AT. Gastrointestinal dysfunction induced by early weaning is attenuated by delayed weaning and mast cell blockade in pigs. Am J Physiol-Gastr L. 2007;293(2):G413–G21.

    CAS  Google Scholar 

  47. 47.

    Xiong X, Yang HS, Wang XC, Hu Q, Liu CX, Wu X, et al. Effect of low dosage of chito-oligosaccharide supplementation on intestinal morphology, immune response, antioxidant capacity, and barrier function in weaned piglets. J Anim Sci. 2015;93(3):1089–97.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  48. 48.

    Ammendolia MG, Iosi F, Maranghi F, Tassinari R, Cubadda F, Aureli F, et al. Short-term oral exposure to low doses of nano-sized TiO2 and potential modulatory effects on intestinal cells. Food Chem Toxicol. 2017;102:63–75.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  49. 49.

    Bettini S, Boutet-Robinet E, Cartier C, Comera C, Gaultier E, Dupuy J, et al. Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon. Sci Rep. 2017;7:40373.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  50. 50.

    Garcia-Rodriguez A, Vila L, Cortes C, Hernandez A, Marcos R. Effects of differently shaped TiO(2)NPs (nanospheres, nanorods and nanowires) on the in vitro model (Caco-2/HT29) of the intestinal barrier. Part Fibre Toxicol. 2018;15(1):33.

  51. 51.

    Riedle S, Pele LC, Otter DE, Hewitt RE, Singh H, Roy NC, et al. Pro-inflammatory adjuvant properties of pigment-grade titanium dioxide particles are augmented by a genotype that potentiates interleukin 1 beta processing. Part Fibre Toxicol. 2017;14(1):51.

  52. 52.

    Bianchi MG, Allegri M, Chiu M, Costa AL, Blosi M, Ortelli S, et al. Lipopolysaccharide adsorbed to the bio-Corona of TiO2 nanoparticles powerfully activates selected pro-inflammatory transduction pathways. Front Immunol. 2017;8:866.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  53. 53.

    Gao Y, Li T, Duan S, Lyu L, Li Y, Xu L, Wang Y. Impact of titanium dioxide nanoparticles on intestinal community in 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced acute colitis mice and the intervention effect of vitamin E. Nanoscale. 2021.

Download references


Not applicable.


This work was supported by the National Natural Science Foundation of China (31971313, 31400863), the National Basic Research Program of China (2017YFC1600200), and  the Beijing Natural Science Foundation (7172116).

Author information




Y.Z. designed the present study, performed all experiments and wrote manuscript. S.D. assisted in animal experiments. Y.L. assisted in interpretation of data. Y.W. conceived the present study, provided overall guidance to the development of the whole study, critically reviewed and revised the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Yun Wang.

Ethics declarations

Ethics approval and consent to participate

All animal procedures were approved by the Peking University Institutional Review Board.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1 Table S1

. Impurity elements of TiO2 NPs and TiO2 MPs (μg/g)

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhang, Y., Duan, S., Liu, Y. et al. The combined effect of food additive titanium dioxide and lipopolysaccharide on mouse intestinal barrier function after chronic exposure of titanium dioxide-contained feedstuffs. Part Fibre Toxicol 18, 8 (2021).

Download citation


  • Titanium dioxide nanoparticle
  • Lipopolysaccharide
  • Nutrient absorption
  • Gut barrier
  • Inflammation